Pro-Dex, Inc.
Pro-Dex, Inc. (PDEX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Pro-Dex, Inc. (PDEX), featuring income statements, balance sheets, and cash flow data.
Pro-Dex, Inc. (PDEX) Income Statement & Financial Overview
View the income breakdown for Pro-Dex, Inc. PDEX across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $16.79M | $14.89M | $15.03M | $14.29M |
| Cost of Revenue | $11.72M | $9.74M | $10.83M | $10.19M |
| Gross Profit | $5.07M | $5.15M | $4.19M | $4.10M |
| Gross Profit Ratio | $0.30 | $0.35 | $0.28 | $0.29 |
| R&D Expenses | $942000.00 | $843000.00 | $836000.00 | $760000.00 |
| SG&A Expenses | $1.44M | $1.29M | $902000.00 | $1.03M |
| Operating Expenses | $2.38M | $2.14M | $1.84M | $1.89M |
| Total Costs & Expenses | $14.10M | $11.88M | $12.67M | $12.08M |
| Interest Income | $21000.00 | $25000.00 | $68000.00 | $30000.00 |
| Interest Expense | $204000.00 | $152000.00 | $149000.00 | $138000.00 |
| Depreciation & Amortization | $313000.00 | $302000.00 | $306000.00 | $286000.00 |
| EBITDA | $3.10M | $3.77M | $2.66M | $2.50M |
| EBITDA Ratio | $0.18 | $0.25 | $0.18 | $0.17 |
| Operating Income | $2.69M | $3.01M | $2.35M | $2.21M |
| Operating Income Ratio | $0.16 | $0.20 | $0.16 | $0.15 |
| Other Income/Expenses (Net) | -$106000.00 | $306000.00 | -$421000.00 | -$1.30M |
| Income Before Tax | $2.59M | $3.32M | $1.93M | $913000.00 |
| Income Before Tax Ratio | $0.15 | $0.22 | $0.13 | $0.06 |
| Income Tax Expense | $546000.00 | $853000.00 | $343000.00 | $258000.00 |
| Net Income | $2.04M | $2.47M | $1.59M | $655000.00 |
| Net Income Ratio | $0.12 | $0.17 | $0.11 | $0.05 |
| EPS | $0.63 | $0.76 | $0.47 | $0.19 |
| Diluted EPS | $0.61 | $0.75 | $0.46 | $0.19 |
| Weighted Avg Shares Outstanding | $3.26M | $3.26M | $3.40M | $3.45M |
| Weighted Avg Shares Outstanding (Diluted) | $3.34M | $3.29M | $3.47M | $3.52M |
Over the past four quarters, Pro-Dex, Inc. demonstrated steady revenue growth, increasing from $14.29M in Q3 2024 to $16.79M in Q2 2025. Operating income reached $2.69M in Q2 2025, maintaining a consistent 16% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $3.10M, reflecting operational efficiency. Net income dropped to $2.04M, with EPS at $0.63. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan